BHF Kleinwort Benson Group’s AbbVie ABBV Stock Holding History

BHF Kleinwort Benson Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$21.8M	Buy	+381,418	New	+$21.3M	0.63%	54
2015 Q4	–	Sell	-652,054	Closed	-$35.5M	–	390
2015 Q3	$35.5M	Buy	652,054 +308,900	+90%	+$20.1M	1.4%	22
2015 Q2	$23.1M	Sell	343,154 -447,777	-57%	-$29.2M	0.78%	36
2015 Q1	$46.8M	Buy	790,931 +173,196	+28%	+$10.5M	1.28%	13
2014 Q4	$43.6M	Buy	617,735 +389,193	+170%	+$24.5M	1.13%	17
2014 Q3	$10.5M	Buy	228,542 +22,881	+11%	+$1.27M	0.34%	83
2014 Q2	$11.6M	Sell	205,661 -61,578	-23%	-$3.23M	0.34%	86
2014 Q1	$12.5M	Buy	267,239 +260,551	+3,896%	+$13.2M	0.36%	81
2013 Q4	$354K	Buy	6,688 +5,788	+643%	+$284K	0.02%	205
2013 Q3	$40K	Hold	900	–	–	0.01%	246
2013 Q2	$37K	Buy	+900	New	+$39.4K	﹤0.01%	232

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BHF Kleinwort Benson Group's ABBV Position: Q1 2016 in Review

BHF Kleinwort Benson Group opened a new position in AbbVie (ABBV) in Q1 2016: 381,418 shares worth $21.8M. The stake represents 0.63% of the portfolio and ranks #54 among its holdings. This is a return to the name: BHF Kleinwort Benson Group previously reported a position in ABBV as recently as Q3 2015.

BHF Kleinwort Benson Group first reported a position in ABBV in Q2 2013 and has held it in 11 quarters since. The position peaked at $46.8M in Q1 2015. 1,639 funds tracked by Wall St. Rank hold ABBV as of Q1 2016.

BHF Kleinwort Benson Group held 381,418 shares of AbbVie worth $21.8M as of Q1 2016.
AbbVie was a new BHF Kleinwort Benson Group position in Q1 2016.
AbbVie made up 0.63% of BHF Kleinwort Benson Group's portfolio in Q1 2016, its #54 holding.
BHF Kleinwort Benson Group first reported a position in AbbVie in Q2 2013 and has held it in 11 quarters since.
BHF Kleinwort Benson Group's AbbVie position peaked at $46.8M in Q1 2015.
1,639 funds tracked by Wall St. Rank held AbbVie as of Q1 2016.

Based on BHF Kleinwort Benson Group's 13F filing for Q1 2016, filed 9 May 2016.